CIRM Takes Steps To Address Potential Conflict of Interest After Former President Joins StemCells Inc.
On Wednesday, the California Institute for Regenerative Medicine said it is addressing a "risk of conflict of interest" after the organization's former president recently was named to the board of directors of StemCells Inc. John Simpson, director of Consumer Watchdog's stem cell project, said the move appears to be a conflict of interest because CIRM had awarded StemCells Inc. $19 million.
- "California Stem Cell Agency To Review Dealings With StemCells Inc." (Khan, "Science Now," Los Angeles Times, 7/10).